Koninklijke Philips N.V.
PHGNLKoninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Enterprise value over trailing (LTM) vs. forward (NTM) fundamentals. Click an LTM cell to chart it.
- Sector
- Medical Devices & Diagnostics
- Sub-sector
- Diagnostics & Imaging
- Listing
- PHG
- Country
- NL
EV / LTM Revenue
Annual financials & analyst forecasts
| $M | CY2021 | CY2022 | CY2024 | CY2025 | CY2026E | CY2027E |
|---|---|---|---|---|---|---|
| Revenue YoY | — | 4% | 1% | -1% | 0% | 4% |
| Revenue | $17.16B | $17.83B | $18.02B | $17.83B | $17.88B | $18.67B |
| Gross Profit | $7.22B | $7.19B | $7.77B | $8.06B | — | — |
| Gross Profit Margin | 42.1% | 40.4% | 43.1% | 45.2% | — | — |
| EBITDA | $1.33B | ($736M) | $848M | $2.63B | $3.92B | $4.09B |
| EBITDA Margin | 7.7% | -4.1% | 4.7% | 14.8% | 21.9% | 21.9% |
| EBIT | $553M | ($1.53B) | $528M | $1.42B | $3.10B | $3.24B |
| Net Income | $3.32B | ($1.61B) | ($702M) | $895M | $1.56B | $1.61B |
| Free Cash Flow | $0M | $104M | ($411M) | $755M | — | — |
| FCF Margin | 0.0% | 0.6% | -2.3% | 4.2% | — | — |
| Short-Term Debt | $53M | $95M | $224M | $1.15B | — | — |
| Long-Term Debt | $4.77B | $6.17B | $6.19B | $6.93B | — | — |
| Cash & Cash Equivalents | $2.30B | $1.17B | $2.40B | $2.79B | — | — |
| Net Debt | $2.52B | $5.09B | $4.02B | $5.29B | — | — |
| Net Debt / EBITDA | 1.9x | — | 4.7x | 2.0x | — | — |
| Rule of 40 | — | 4.5% | -1.2% | 3.2% | — | — |